Abstract
The onset of autoantibodies in systemic autoimmunity can be the result of a breakdown in tolerance at multiple checkpoints. Genetic, hormonal, and immunological factors can combine with environmental influences to accelerate the onset of disease and aggravate disease outcome. Here, we describe a novel mechanism relating to the regulatory role of Neutrophil Gelatinase Associated Lipocalin (NGAL) in modulating the levels of autoantibodies in pristane induced lupus. Following a single injection of pristane intraperitoneally, NGAL expression was induced in both the serum and spleen. Furthermore, NGAL deficient mice were more susceptible to the induction of pristane stimulated autoimmunity, and displayed higher numbers of autoantibody secreting cells and increased expression of activation induced cytidine deaminase (AID) and other inflammatory mediators in the spleen. In contrast, kidney damage was milder in NGAL deficient mice, indicating that NGAL was detrimental in autoantibody mediated kidney disease. These studies indicate that NGAL plays differential roles in different tissues in the context of lupus, and suggest a previously unrecognized role for NGAL in adaptive immunity.
Original language | English |
---|---|
Pages (from-to) | 49-65 |
Number of pages | 17 |
Journal | Clinical Immunology |
Volume | 154 |
Issue number | 1 |
DOIs | |
State | Published - Sep 2014 |
Externally published | Yes |
Bibliographical note
Funding Information:This study was supported by grants from the −/− mice. The authors would like to acknowledge the laboratory of Dr. Richard Stanley (Albert Einstein College of Medicine) for their help in macrophage isolation. NIH RO1-AR048692 and RO1-DK090319 (to C.P.) and an Arthritis Foundation fellowship (# 5451 ) (to R.D.P.). Westley H. Reeves and Haoyang Zhuang were supported by grants RO1-AR44731 and T32AR007603 respectively. The authors thank Drs. Thorsten Berger and Tak W. Mak (Ontario Cancer Institute, Canada) for generously providing the NGAL
Funding
This study was supported by grants from the −/− mice. The authors would like to acknowledge the laboratory of Dr. Richard Stanley (Albert Einstein College of Medicine) for their help in macrophage isolation. NIH RO1-AR048692 and RO1-DK090319 (to C.P.) and an Arthritis Foundation fellowship (# 5451 ) (to R.D.P.). Westley H. Reeves and Haoyang Zhuang were supported by grants RO1-AR44731 and T32AR007603 respectively. The authors thank Drs. Thorsten Berger and Tak W. Mak (Ontario Cancer Institute, Canada) for generously providing the NGAL
Funders | Funder number |
---|---|
National Institutes of Health | RO1-AR048692 |
National Institute of Diabetes and Digestive and Kidney Diseases | R01DK090319 |
Arthritis Foundation | 5451, T32AR007603, RO1-AR44731 |
Keywords
- Autoantibodies
- Lipocalin-2
- NGAL
- Pristane
- SLE